Community Practice

A survey of new Rx, new generic, and new OTC products

After attending a high school reunion, a pharmacist reflects on what he'd learn through a reunion of his pharmacy career.

The first in a series of articles on the work that social media can do for pharmacists,

Readers discuss taking the time to research, the need for care when purchasing drugs, the need to be more visible to the public, and arguing that cyberconsulting is too dangerous to practice in.

A look at the meningitis outbreak that killed 36 and whether or not legislation could prevent a similar tragedy from occurring.

The fungal meningitis outbreak can serve as a reminder of the need for risk management.

Two pharmacy students argue that the push needs to continue for attaining provider status and it's important to include students.

The National Community Pharmacist Association (NCPA) teamed up with Purdue Pharma L.P. to introduce the fourth annual pharmacy safety and security video at www.RxPATROL.org.

Thousands of patients who attended one of 65 health fairs held throughout the United States were educated about the ABCS of heart health, thanks to $35,000 in grant money from the National Association of Chain Drug Stores (NACDS) Foundation.

James D. Coffey, RPh, director of the Massachusetts Board of Registration in Pharmacy, has been removed from his position after allegedly failing to follow up on a complaint about the New England Compounding Pharmacy (NECC) from the Colorado Board of Pharmacy in July.

The Advisory Committee on Immunization Practices (ACIP) has approved revisions to the measles, mumps, and rubella (MMR) vaccine recommendations for individuals with HIV infection, for those with evidence of immunity, and for those at high risk who have been exposed to measles, according to a report published by Medscape Medical News.

A look at how both chain pharmacies and independents are working on providing better diabetes care.

Metformin is one of the most important pharmacologic agents for diabetes, but patients need more to maintain optimal HbA1c levels.

While MTM is proving to be effective, a different version, collaborative drug therapy management could be the best model for diseases like diabetes.

Blood glucose control is the focus of diabetes care, but a holistic approach is needed to meet all of a patient's needs.

Blood glucose meters have come a long way and the newest models can track patterns, in addition to the standard monitoring.

This Nov. 10 marks the 40th anniversary of the pharmacy stamp that was issued to commemorate the profession.

The safe disposal of drugs helps more than just patients.

Medication therapy management offers pharmacists a chance to provide more patient care. MTM also provides a way to compensate pharmacists for these services.

A pharmacist muses on how being successful can lead to not questioning the status quo.

FDA approved a single shared Risk Evaluation and Mitigation Strategy (REMS) for all mycophenolate-containing prescription drugs at the end of September.

The results of a recent survey may come as no surprise to many pharmacists-that time constraints can have an effect on the community practice setting and patient safety.

The Massachusetts Department of Health (DPH) announced Oct. 28 at a press conference that it will be adding five more inspectors to the Board of Pharmacy to continue its investigation of the New England Compounding Center, the Ameridose pharmacy, and other unannounced inspections at compounding pharmacies that prepare sterile injectables.

Cleansing laxatives approved for prescription use before colonscopy

A round-up of OTC products that help lips brave the winter weather.

A pharmacist describes an evening that he feels is typical of being a pharmacist and crystalizes how pharmacists are important.

Is your health system is having an epidemic of CLABSIs? CUSP can help save lives and money.

FDA and the CDC confirm that the fungus Exserohilium rostratum contaminated one of the three implicated lots of preservative-free methylprednisone acetate (80 mg/mL) from the New England Compounding Center which the company recalled September 26.

A look at how technology is changing the treatment of diabetes.

Anticoagulation therapies reviewed, including Merck moving forward with FDA approval of vorapaxar despite bleeding risks